COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04158739
Brief Title: Flotetuzumab for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

First Submitted : October 15, 2019
First Submitted that Met QC Criteria : November 6, 2019
First Posted : November 12, 2019

Last Update Submitted that Met QC Criteria : March 17, 2020
Last Update Posted : March 19, 2020